GlobeNewswire Inc.··Robbins LlpInovio Pharmaceuticals Faces Class Action Over Device Manufacturing Disclosures
Inovio Pharmaceuticals faces class action lawsuit for allegedly misleading investors about device manufacturing capabilities and regulatory delays, leading to 24% stock decline.
INOsecurities fraudclass action lawsuit